Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

Müller, N, Schwarz, M J · 2007 · Molecular Psychiatry

Abstract

Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4002006

Cites

218 of 218 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 220 references

Research works printed but not linked: 5

  1. Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
  2. Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
  3. Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
  4. Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
  5. Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.

Cited by

See all 681

Metadata

Authors
Müller, N., & Schwarz, M. J.
Affiliations
Ludwig-Maximilians-Universität München (DE)
Venue
Molecular Psychiatry
Published
2007-04-24
Volume
12
Issue
11
Pages
988-1000
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2002250647
Cited by
670
References
220
Citations by year
2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
FWCI
1.44
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
MeSH terms
Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. https://app.cochat.ai/papers/10.1038/sj.mp.4002006
The paper
Müller, N., & Schwarz, M. J. (2007). The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Molecular Psychiatry. https://doi.org/10.1038/sj.mp.4002006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.